Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04197986
Brief Title: Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

First Submitted : December 2, 2019
First Submitted that Met QC Criteria : December 12, 2019
First Posted : December 13, 2019

Last Update Submitted that Met QC Criteria : July 29, 2021
Last Update Posted : August 2, 2021